Skip to content
41

enclomiphene

Skip it

Weak search conversion (1.1%) — this niche doesn't clear our bar today.

Market size 23Growth 44Conversion 13Competition 15Returns 100Price range 41Avg price 87Brand share 33Review moat 39Quality gap 60

Returns

Incredible0.0%

return rate — above 5% kills the launch gate

Avg price

Great$68.00

avg listing price — sweet spot $15–$100

Quality gap

Good4.4★

avg incumbent rating — lower means beatable quality

Growth

Okay+15.2%

90-day search growth — must beat 0% to launch

Price range

Okay$10.67–$218.86

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Okay2,619.33

avg incumbent reviews — the moat a new listing must climb

Brand share

Okay85%

top-5 brand share — brands hold most of the demand

Market size

Bad$93K

$93K/yr · 130K searches

Competition

Bad82%

top-5 click share — a locked-up shelf

Conversion

Bad1.1%

search→purchase rate — share of searches ending in a sale

Products